Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 14, 2022

Primary Completion Date

June 6, 2024

Study Completion Date

October 31, 2024

Conditions
StrokeSilent Cerebral InfarctionNeurocognitive DysfunctionVascular Brain Injury
Interventions
OTHER

CO2 flushing

As above

OTHER

Saline flushing

As above

Trial Locations (1)

W2 1NY

RECRUITING

Imperial College London, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Imperial College Healthcare NHS Trust

OTHER

collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

collaborator

St George's University Hospitals NHS Foundation Trust

OTHER

collaborator

University Hospitals Coventry and Warwickshire NHS Trust

OTHER

collaborator

South Canterbury DHB, New Zealand

UNKNOWN

collaborator

Baylor Scott and White Health

OTHER

collaborator

University Hospital Southampton NHS Foundation Trust

OTHER

collaborator

Health New Zealand

UNKNOWN

lead

Imperial College London

OTHER

NCT03886675 - Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection | Biotech Hunter | Biotech Hunter